Chabner Ba
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Oncology top 10%
- Viral-associated cancers and disorders
- Drug Transport and Resistance Mechanisms
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 2
-
- Lymphoma Diagnosis and Treatment 5
- Co-authors
- DeVita Vt (6 shared papers)Myers Ce (2 shared papers)Oliverio Vt (1 shared paper)RC Young (3 shared papers)Fisher Ri (3 shared papers)Donehower Rc (1 shared paper)Larry Norton (1 shared paper)T Anderson (1 shared paper)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (2 papers)PubMed (19 papers)
- Partner nations
- United StatesMalaysia
In The Last Decade
Chabner Ba
20 papers receiving 420 citations
Peers
Comparison fields: 5 of 76
- Pathology and Forensic Medicine 167
- Oncology 238
- Genetics 72
- Hematology 48
- Neurology 52
Countries citing papers authored by Chabner Ba
This map shows the geographic impact of Chabner Ba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chabner Ba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chabner Ba more than expected).
Fields of papers citing papers by Chabner Ba
This network shows the impact of papers produced by Chabner Ba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chabner Ba. The network helps show where Chabner Ba may publish in the future.
Co-authors
The 16 scholars most cited alongside Chabner Ba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Drug resistance in cancer. | 1984 | 137 |
| 2 | Combination chemotherapy in non-Hodgkin's lymphoma: results of long-term followup. | 1977 | 88 |
| 3 | Clinical pharmacology of anticancer drugs. | 1977 | 73 |
| 4 | Sequential staging in non-Hodgkin's lymphoma. | 1977 | 34 |
| 5 | Clinical pharmacology of methotrexate. | 1981 | 34 |
| 6 | Staging of non-Hodgkin's lymphoma. | 1980 | 30 |
| 7 | Preliminary Results of trials of chemotherapy in advanced ovarian carcinoma. | 1975 | 13 |
| 8 | Allergic reaction to cyclophosphamide in a mechlorethamine-sensitive patient. | 1977 | 12 |
| 9 | Drug resistance in adult lymphomas. | 1994 | 12 |
| 10 | Enrichment of myeloid progenitor cells from normal human bone marrow using an immune-rosette technique. | 1985 | 9 |
| 11 | High-dose intermittent intravenous infusion of procarbazine (NSC-77213). | 1974 | 7 |
| 12 | National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Editorial overview. | 1986 | 7 |
| 13 | Competitive protein-binding assay for trimetrexate. | 1985 | 7 |
| 14 | Symposium on cellular resistance to anticancer drugs. Introduction. | 1983 | 7 |
| 15 | The lymphomas: biologic implications of therapy and therapeutic implications of the new biology. | 1987 | 4 |
| 16 | Surgical oncology research development: the perspective of the National Cancer Institute. | 1984 | 3 |
| 17 | Antifolate metabolism and sites of action: implications for the design of new antifolates. | 1987 | 2 |
| 18 | Phase II study of high-dose methotrexate in patients with advanced malignant melanoma. | 1979 | 2 |
| 19 | Proceedings: Malignant lymphoma: treatment with combination chemotherapy. | 1972 | 1 |
| 20 | Multidrug resistance: mechanism and therapy. | 1993 | 1 |
About Chabner Ba
Chabner Ba is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Oncology and Public Health, Environmental and Occupational Health, having authored 21 papers that have together received 483 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Lung Cancer Treatments and Mutations (4 papers), Acute Lymphoblastic Leukemia research (3 papers), Cancer Treatment and Pharmacology (2 papers), Cancer therapeutics and mechanisms (2 papers), HER2/EGFR in Cancer Research (2 papers), Folate and B Vitamins Research (2 papers) and Multiple and Secondary Primary Cancers (2 papers). The work is most often cited by research in Pathology and Forensic Medicine (167 citations), Oncology (238 citations), Genetics (72 citations), Hematology (48 citations) and Neurology (52 citations). Chabner Ba has collaborated with scholars based in United States and Malaysia. Frequent co-authors include DeVita Vt, Myers Ce, Oliverio Vt, RC Young, Fisher Ri, Donehower Rc, Larry Norton, T Anderson, Young Rc and Canellos Gp. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.